Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $14.1700 (5.43%) ($13.3500 - $14.2000) on Mon. Jun. 19, 2017. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.69% (three month average) | RSI | 79 | Latest Price | $14.1700(5.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO advances 2% a day on average for past five trading days. | Weekly Trend | HALO advances 4.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(52%) IWM(49%) ARKG(48%) | Factors Impacting HALO price | HALO will decline at least -1.345% in a week (0% probabilities). VIXM(-13%) UUP(-10%) TLT(-6%) SHY(-3%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.345% (StdDev 2.69%) | Hourly BBV | 0 () | Intraday Trend | 5.7% | | | |
|
5 Day Moving Average | $13.41(5.67%) | 10 Day Moving Average | $13.14(7.84%) | 20 Day Moving Average | $12.83(10.44%) | To recent high | -2.8% | To recent low | 20.1% | Market Cap | $1.937b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |